Personalized Medicine Leads to Better Outcomes for Patients with Cancer

In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.

The findings are published in the June 6, 2016 issue of JAMA Oncology. … Read the Full Story from the UC San Diego Newsroom


Dr. Razelle Kurzrock

Dr. Razelle Kurzrock

The senior author of the report in JAMA Oncology is Razelle Kurzrock, MD, Director of the Center for Personalized Cancer Therapy and Clinical Trials Office at Moores Cancer Center.

Dr. Kurzrock is Chief of the Division of Hematology-Oncology in the Department of Medicine.

$1 Million Gift from Joan and Irwin Jacobs Supports New Center for Personalized Cancer Therapy

A leadership gift of $1 million from San Diego philanthropists Joan and Irwin Jacobs will help UC San Diego Moores Cancer Center change how cancer is treated by supporting the Center for Personalized Cancer Therapy, a newly established center headed by Razelle Kurzrock, M.D. The UC San Diego Moores Cancer Center is one of just 41 National Cancer Institute-designated Comprehensive Cancer Centers in the United States, and the only one in the San Diego region. … Read the full story from the UCSD Newsroom


Dr. Razelle KurzrockPhysician-scientist Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science at the Moores Cancer Center. There, she directs the Clinical Trials Office as well as the Center for Personalized Cancer Therapy.

Kurzrock is professor of medicine and vice chief of the Division of Hematology-Oncology at UC San Diego.